Drug Information

Drug General Information
Drug ID
D08MPA
Former ID
DIB009393
Drug Name
AMA-76
Indication Glaucoma [ICD9: 365; ICD10:H40-H42] Phase 2 [524752]
Company
Amakem
Target and Pathway
Target(s) Rho associated protein kinase Target Info Modulator [532649]
References
Ref 524752ClinicalTrials.gov (NCT02136940) Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension. U.S. National Institutes of Health.
Ref 532649AMA0076, a novel, locally acting Rho kinase inhibitor, potently lowers intraocular pressure in New Zealand white rabbits with minimal hyperemia. Invest Ophthalmol Vis Sci. 2014 Feb 18;55(2):1006-16.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.